Arcadia Biosciences Shares Plunge Afterhours As Q4 Earnings Miss Estimates

  • Arcadia Biosciences Inc RKDA reported fourth-quarter revenue declined 70% year-over-year to $2.17 million, missing the consensus of $3.33 million.
  • Net loss was $(9.3) million of $(0.42) per share, compared to the $8.9 million of income recognized in 4Q20, missing the consensus of $(0.30).
  • RKDA reported a loss from operations of $(13.04) million for the quarter, compared to an income of $7.46 million a year ago.
  • Net cash used in operating activities for FY21 totaled $25.87 million, compared to $30.22 million in FY20.
  • Arcadia Biosciences held cash and cash equivalents of $28.68 million as of December 31, 2021.
  • RKDA shares have gained about 60.2% year-to-date
  • Price Action: RKDA shares are trading lower by 30.20% at $1.32 during the post-market session on Wednesday.
Loading...
Loading...
RKDA Logo
RKDAArcadia Biosciences Inc
$4.60-%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
94.48
Growth
21.73
Quality
Not Available
Value
79.01
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Comments
Loading...